ID   SIAH1_RAT               Reviewed;         282 AA.
AC   Q920M9; Q06984;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 2.
DT   29-MAY-2024, entry version 169.
DE   RecName: Full=E3 ubiquitin-protein ligase SIAH1;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:11786535, ECO:0000269|PubMed:15951807};
DE   AltName: Full=RING-type E3 ubiquitin transferase SIAH1 {ECO:0000305};
DE   AltName: Full=Seven in absentia homolog 1;
DE            Short=Siah-1;
DE   AltName: Full=Siah-1a;
GN   Name=Siah1; Synonyms=Siah1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION IN DEGRADATION OF SYP, CATALYTIC
RP   ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND INTERACTION WITH UBE2E2.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11786535; DOI=10.1074/jbc.m107857200;
RA   Wheeler T.C., Chin L.-S., Li Y., Roudabush F.L., Li L.;
RT   "Regulation of synaptophysin degradation by mammalian homologues of Seven
RT   in Absentia.";
RL   J. Biol. Chem. 277:10273-10282(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yamaguchi A., Hori O., Tohyama M.;
RT   "Rat Siah1A.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH GRM1 AND GRM5.
RX   PubMed=10469171; DOI=10.1046/j.1365-2443.1999.00269.x;
RA   Ishikawa K., Nash S.R., Nishimune A., Neki A., Kaneko S., Nakanishi S.;
RT   "Competitive interaction of seven in absentia homolog-1A and
RT   Ca2+/calmodulin with the cytoplasmic tail of group 1 metabotropic glutamate
RT   receptors.";
RL   Genes Cells 4:381-390(1999).
RN   [4]
RP   INTERACTION WITH SNCAIP.
RX   PubMed=15064394; DOI=10.1073/pnas.0401081101;
RA   Liani E., Eyal A., Avraham E., Shemer R., Szargel R., Berg D.,
RA   Bornemann A., Riess O., Ross C.A., Rott R., Engelender S.;
RT   "Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence
RT   in cellular inclusions and Lewy bodies imply a role in Parkinson's
RT   disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:5500-5505(2004).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH GAPDH.
RX   PubMed=15951807; DOI=10.1038/ncb1268;
RA   Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y.,
RA   Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., Ferris C.D.,
RA   Hayward S.D., Snyder S.H., Sawa A.;
RT   "S-nitrosylated GAPDH initiates apoptotic cell death by nuclear
RT   translocation following Siah1 binding.";
RL   Nat. Cell Biol. 7:665-674(2005).
RN   [6]
RP   INTERACTION WITH SNCAIP, AND SUBCELLULAR LOCATION.
RX   PubMed=19224863; DOI=10.1074/jbc.m805990200;
RA   Szargel R., Rott R., Eyal A., Haskin J., Shani V., Balan L., Wolosker H.,
RA   Engelender S.;
RT   "Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates
RT   alpha-synuclein monoubiquitylation and inclusion formation.";
RL   J. Biol. Chem. 284:11706-11716(2009).
RN   [7]
RP   INTERACTION WITH BSN AND PCLO.
RX   PubMed=23403927; DOI=10.1038/emboj.2013.27;
RA   Waites C.L., Leal-Ortiz S.A., Okerlund N., Dalke H., Fejtova A.,
RA   Altrock W.D., Gundelfinger E.D., Garner C.C.;
RT   "Bassoon and Piccolo maintain synapse integrity by regulating protein
RT   ubiquitination and degradation.";
RL   EMBO J. 32:954-969(2013).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and
CC       subsequent proteasomal degradation of target proteins (PubMed:11786535,
CC       PubMed:15951807). E3 ubiquitin ligases accept ubiquitin from an E2
CC       ubiquitin-conjugating enzyme in the form of a thioester and then
CC       directly transfers the ubiquitin to targeted substrates
CC       (PubMed:11786535, PubMed:15951807). Mediates E3 ubiquitin ligase
CC       activity either through direct binding to substrates or by functioning
CC       as the essential RING domain subunit of larger E3 complexes
CC       (PubMed:11786535, PubMed:15951807). Triggers the ubiquitin-mediated
CC       degradation of many substrates, including proteins involved in
CC       transcription regulation (ELL2, MYB, POU2AF1, PML and RBBP8), a cell
CC       surface receptor (DCC), cytoplasmic signal transduction molecules
CC       (KLF10/TIEG1 and NUMB), an antiapoptotic protein (BAG1), a microtubule
CC       motor protein (KIF22), a protein involved in synaptic vesicle function
CC       in neurons (SYP), a structural protein (CTNNB1) and SNCAIP
CC       (PubMed:11786535). Confers constitutive instability to HIPK2 through
CC       proteasomal degradation (By similarity). It is thereby involved in many
CC       cellular processes such as apoptosis, tumor suppression, cell cycle,
CC       axon guidance, transcription, spermatogenesis and TNF-alpha signaling
CC       (By similarity). Has some overlapping function with SIAH2 (By
CC       similarity). Induces apoptosis in cooperation with PEG3 (By
CC       similarity). Upon nitric oxid (NO) generation that follows apoptotic
CC       stimulation, interacts with S-nitrosylated GAPDH, mediating the
CC       translocation of GAPDH to the nucleus (PubMed:15951807). GAPDH acts as
CC       a stabilizer of SIAH1, facilitating the degradation of nuclear proteins
CC       (PubMed:15951807). Mediates ubiquitination and degradation of EGLN2 and
CC       EGLN3 in response to the unfolded protein response (UPR), leading to
CC       their degradation and subsequent stabilization of ATF4 (By similarity).
CC       Also part of the Wnt signaling pathway in which it mediates the Wnt-
CC       induced ubiquitin-mediated proteasomal degradation of AXIN1.
CC       {ECO:0000250|UniProtKB:P61092, ECO:0000250|UniProtKB:Q8IUQ4,
CC       ECO:0000269|PubMed:11786535, ECO:0000269|PubMed:15951807}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:11786535,
CC         ECO:0000269|PubMed:15951807};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:11786535, ECO:0000269|PubMed:15951807}.
CC   -!- SUBUNIT: Homodimer. Component of some large E3 complex composed of
CC       UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X. Interacts with UBE2I.
CC       Interacts with alpha-tubulin. Interacts with PEG10, which may inhibit
CC       its activity. Interacts with PEG3 and HIPK2 (By similarity). Interacts
CC       with group 1 glutamate receptors GRM1 and GRM5. Interacts with DAB1,
CC       which may inhibit its activity. Interacts with UBE2E2. Interacts with
CC       SNCAIP. Interacts with HIPK2; the interaction is promoted by DAZAP2 and
CC       results in SIAH1-mediated ubiquitination and subsequent proteasomal
CC       degradation of HIPK2 (By similarity). Interacts with DAZAP2; the
CC       interaction is decreased following phosphorylation of DAZAP2 by HIPK2
CC       (By similarity). Interacts with GAPDH; leading to stabilize SIAH1.
CC       Interacts with Bassoon/BSN and Piccolo/PLCO; these interactions
CC       negatively regulate SIAH1 E3 ligase activity. Interacts with DCC (By
CC       similarity). Interacts with AXIN1; catalyzes AXIN1 ubiquitination and
CC       subsequent proteasome-mediated ubiquitin-dependent degradation.
CC       {ECO:0000250|UniProtKB:P61092, ECO:0000250|UniProtKB:Q8IUQ4,
CC       ECO:0000269|PubMed:10469171, ECO:0000269|PubMed:11786535,
CC       ECO:0000269|PubMed:15064394, ECO:0000269|PubMed:15951807,
CC       ECO:0000269|PubMed:19224863, ECO:0000269|PubMed:23403927}.
CC   -!- INTERACTION:
CC       Q920M9; O88778: Bsn; NbExp=3; IntAct=EBI-957514, EBI-2271660;
CC       Q920M9; Q9JKS6: Pclo; NbExp=2; IntAct=EBI-957514, EBI-2271602;
CC       Q920M9; Q71F54: Sh3rf1; NbExp=2; IntAct=EBI-957514, EBI-957526;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Predominantly
CC       cytoplasmic. Partially nuclear.
CC   -!- DOMAIN: The RING-type zinc finger domain is essential for ubiquitin
CC       ligase activity. {ECO:0000250}.
CC   -!- DOMAIN: The SBD domain (substrate-binding domain) mediates the
CC       homodimerization and the interaction with substrate proteins. It is
CC       related to the TRAF family. {ECO:0000250|UniProtKB:P61092}.
CC   -!- PTM: Phosphorylated on Ser-19 by ATM and ATR. This phosphorylation
CC       disrupts SIAH1 interaction with HIPK2, and subsequent proteasomal
CC       degradation of HIPK2 (By similarity). {ECO:0000250|UniProtKB:Q8IUQ4}.
CC   -!- SIMILARITY: Belongs to the SINA (Seven in absentia) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB70753.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF389476; AAL91362.1; -; mRNA.
DR   EMBL; AB067814; BAB70753.1; ALT_INIT; mRNA.
DR   RefSeq; NP_543181.2; NM_080905.2.
DR   RefSeq; XP_008770567.1; XM_008772345.2.
DR   AlphaFoldDB; Q920M9; -.
DR   SMR; Q920M9; -.
DR   BioGRID; 250875; 8.
DR   DIP; DIP-35686N; -.
DR   IntAct; Q920M9; 4.
DR   MINT; Q920M9; -.
DR   STRING; 10116.ENSRNOP00000020329; -.
DR   PhosphoSitePlus; Q920M9; -.
DR   PaxDb; 10116-ENSRNOP00000020329; -.
DR   Ensembl; ENSRNOT00000020329.7; ENSRNOP00000020329.5; ENSRNOG00000015143.7.
DR   Ensembl; ENSRNOT00000097354.1; ENSRNOP00000092754.1; ENSRNOG00000015143.7.
DR   Ensembl; ENSRNOT00000111812.1; ENSRNOP00000089183.1; ENSRNOG00000015143.7.
DR   Ensembl; ENSRNOT00000112896.1; ENSRNOP00000092688.1; ENSRNOG00000015143.7.
DR   Ensembl; ENSRNOT00000117078.1; ENSRNOP00000088384.1; ENSRNOG00000015143.7.
DR   Ensembl; ENSRNOT00055033349; ENSRNOP00055027060; ENSRNOG00055019541.
DR   Ensembl; ENSRNOT00055033357; ENSRNOP00055027066; ENSRNOG00055019541.
DR   Ensembl; ENSRNOT00055033362; ENSRNOP00055027071; ENSRNOG00055019541.
DR   Ensembl; ENSRNOT00055033367; ENSRNOP00055027076; ENSRNOG00055019541.
DR   Ensembl; ENSRNOT00055033370; ENSRNOP00055027079; ENSRNOG00055019541.
DR   Ensembl; ENSRNOT00060025277; ENSRNOP00060020137; ENSRNOG00060014793.
DR   Ensembl; ENSRNOT00060025283; ENSRNOP00060020143; ENSRNOG00060014793.
DR   Ensembl; ENSRNOT00060025287; ENSRNOP00060020147; ENSRNOG00060014793.
DR   Ensembl; ENSRNOT00060025289; ENSRNOP00060020149; ENSRNOG00060014793.
DR   Ensembl; ENSRNOT00060025293; ENSRNOP00060020153; ENSRNOG00060014793.
DR   Ensembl; ENSRNOT00065016573; ENSRNOP00065012616; ENSRNOG00065010264.
DR   Ensembl; ENSRNOT00065016577; ENSRNOP00065012620; ENSRNOG00065010264.
DR   Ensembl; ENSRNOT00065016583; ENSRNOP00065012626; ENSRNOG00065010264.
DR   Ensembl; ENSRNOT00065016585; ENSRNOP00065012628; ENSRNOG00065010264.
DR   Ensembl; ENSRNOT00065016590; ENSRNOP00065012633; ENSRNOG00065010264.
DR   GeneID; 140941; -.
DR   KEGG; rno:140941; -.
DR   AGR; RGD:620449; -.
DR   CTD; 6477; -.
DR   RGD; 620449; Siah1.
DR   eggNOG; KOG3002; Eukaryota.
DR   GeneTree; ENSGT00940000154837; -.
DR   HOGENOM; CLU_028215_0_0_1; -.
DR   InParanoid; Q920M9; -.
DR   OrthoDB; 222086at2759; -.
DR   PhylomeDB; Q920M9; -.
DR   TreeFam; TF312976; -.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q920M9; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000015143; Expressed in cerebellum and 20 other cell types or tissues.
DR   ExpressionAtlas; Q920M9; baseline and differential.
DR   GO; GO:0030877; C:beta-catenin destruction complex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; ISO:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007141; P:male meiosis I; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0030163; P:protein catabolic process; ISO:RGD.
DR   GO; GO:0031648; P:protein destabilization; IMP:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   CDD; cd03829; Sina; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 2.
DR   InterPro; IPR018121; 7-in-absentia-prot_TRAF-dom.
DR   InterPro; IPR004162; SINA-like_animal.
DR   InterPro; IPR049548; Sina-like_RING.
DR   InterPro; IPR008974; TRAF-like.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR013010; Znf_SIAH.
DR   PANTHER; PTHR45877:SF7; E3 UBIQUITIN-PROTEIN LIGASE SIAH1; 1.
DR   PANTHER; PTHR45877; E3 UBIQUITIN-PROTEIN LIGASE SIAH2; 1.
DR   Pfam; PF21362; Sina_RING; 1.
DR   Pfam; PF03145; Sina_TRAF; 1.
DR   Pfam; PF21361; Sina_ZnF; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF49599; TRAF domain-like; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS51081; ZF_SIAH; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell cycle; Cytoplasm; Developmental protein; Differentiation;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Spermatogenesis; Transferase; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..282
FT                   /note="E3 ubiquitin-protein ligase SIAH1"
FT                   /id="PRO_0000056166"
FT   ZN_FING         41..76
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         93..153
FT                   /note="SIAH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00455"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          90..282
FT                   /note="SBD"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         98
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         105
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         117
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         121
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         128
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         135
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         147
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   BINDING         152
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
FT   MOD_RES         19
FT                   /note="Phosphoserine; by ATM and ATR"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUQ4"
SQ   SEQUENCE   282 AA;  31137 MW;  852EADC5DD4A4FFA CRC64;
     MSRQTATALP TGTSKCPPSQ RVPALTGTTA SNNDLASLFE CPVCFDYVLP PILQCQSGHL
     VCSNCRPKLT CCPTCRGPLG SIRNLAMEKV ANSVLFPCKY ASSGCEITLP HTEKAEHEEL
     CEFRPYSCPC PGASCKWQGS LDAVMPHLMH QHKSITTLQG EDIVFLATDI NLPGAVDWVM
     MQSCFGFHFM LVLEKQEKYD GHQQFFAIVQ LIGTRKQAEN FAYRLELNGH RRRLTWEATP
     RSIHEGIATA IMNSDCLVFD TSIAQLFAEN GNLGINVTIS MC
//
